2nd August 2023
11th July 2023
Crossbow Therapeutics Launches with $80 Million Series A Financing to Advance a Novel Class of Antibody Therapies to Treat Cancer
24th May 2023
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
23rd May 2023
ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine
27th April 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing
10th January 2023
NextPoint Therapeutics Announces $80 Million Series B Financing to Advance Novel Immuno-Oncology Programs
9th September 2022
Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules to Modulate and Repair Disease-Driving Proteins
31st August 2022
Umoja’s Unified Approach to Exceeding the Limitations of Cell Therapy
25th August 2022
Aktis Oncology Raises $84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals
18th August 2022